Hepatitis B virus polymerase suppresses NF-?B signaling by inhibiting the activity of IKKs via interaction with Hsp90?.

ABSTRACT: Nuclear factor-?B (NF-?B) plays a central role in the regulation of diverse biological processes, including immune responses, development, cell growth, and cell survival. To establish persistent infection, many viruses have evolved strategies to evade the host's antiviral immune defenses. In the case of hepatitis B virus (HBV), which can cause chronic infection in the liver, immune evasion strategies used by the virus are not fully understood. It has recently been reported that the polymerase of HBV (Pol) inhibits interferon-? (IFN-?) activity by disrupting the interaction between IKK? and the DDX3. In the current study, we found that HBV Pol suppressed NF-?B signaling, which can also contribute to IFN-? production. HBV Pol did not alter the level of NF-?B expression, but it prevented NF-?B subunits involved in both the canonical and non-canonical NF-?B pathways from entering the nucleus. Further experiments demonstrated that HBV Pol preferentially suppressed the activity of the I?B kinase (IKK) complex by disrupting the association of IKK/NEMO with Cdc37/Hsp90, which is critical for the assembly of the IKK complex and recruitment of the IKK complex to the tumor necrosis factor type 1 receptor (TNF-R1). Furthermore, we found that HBV Pol inhibited the NF-?B-mediated transcription of target genes. Taken together, it is suggested that HBV Pol could counteract host innate immune responses by interfering with two distinct signaling pathways required for IFN-? activation. Our studies therefore shed light on a potential therapeutic target for persistent infection with HBV.

SUBMITTER: Liu D 

PROVIDER: S-EPMC3950214 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature